This HTRF enables the cell-based quantitative detection of Alpha-Synuclein when phosphorylated at Ser129 and aggregated.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Monitoring the phosphorylation and aggregation states of alpha-synuclein is of great interest for studying the pathogenesis of synucleinopathies, a group of neurodegenerative diseases that includes Parkinson's disease (PD), dementia with Lewy bodies (DLB), diffuse Lewy body disease (DLBD), and multiple system atrophy (MSA). The kit provides a solution to rapidly detect and quantify protein aggregates of human alpha-synuclein in cell culture or brain tissue extracts.
Application |
Cell Signaling
|
---|---|
Brand |
HTRF
|
Detection Modality |
HTRF
|
Molecular Modification |
Phosphorylation
|
Product Group |
Kit
|
Sample Volume |
16 µL
|
Shipping Conditions |
Shipped in Dry Ice
|
Target Class |
Phosphoproteins
|
Technology |
TR-FRET
|
Unit Size |
500 Assay Points
|
Alpha-Synuclein aggregates are measured using a sandwich immunoassay involving an anti-a Synuclein monoclonal antibody specific for phospho-Ser129 Alpha-Synuclein aggregates labelled with terbium-Cryptate or d2, ensuring assay quality, reproducibility, and signal quality. The specific HTRF signal generated is proportional to the alpha-Synuclein aggregates.
The sample or brain extracts are transferred to the assay plate for the detection of Alpha-Synuclein aggregates. The antibodies labelled with HTRF fluorophores may be pre-mixed and added in a single dispensing step to further streamline the assay procedure. The assay detection can be run in 96- to 384-well plates by simply resizing each addition volume proportionally.
A sample generated with aggregated phospho-Alpha-Synuclein (S129) was purified by exclusion phase (G25), resulting in 3 peaks corresponding respectively to oligomers, dimers, and monomers of phospho-Alpha-Synuclein.
Each sample resulting from this purification step was serial-diluted 14 times and plated at 16 µL/well in a low volume white microplate.
2µL of the HTRF d2 detection reagent and 2µL of the HTRF Eu-Tb detection reagent were added, and the signal was recorded after an overnight incubation at RT.
The results show significant detection of the oligomer aggregates only. Closer examinations of the dimer aggregates' detection showed a lower but still detectable signal. Monomers were not detected, demonstrating the specificity of the assay for aggregates only.
Discover the versatility and precision of Homogeneous Time-Resolved Fluorescence (HTRF) technology. Our HTRF portfolio offers a...
This guide provides you an overview of HTRF applications in several therapeutic areas.
This document includes detailed tables listing HTRF™, AlphaLISA™ SureFire® Ultra™, and Alpha SureFire® Ultra™ Multiplex assays...
Are you looking for technical documents related to the product? We have categorized them in dedicated sections below. Explore now.
We are here to answer your questions.